Form 4 for ELV Elevance Health
Accepted 2025-09-04 00:00:00 ET · period of report 2025-09-02 · accession 0002084547-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-04 | 2025-09-02 | ELV | Craig Ryan R | EVP, Chief HR Off | A - Grant | $0.00 | +970 | 5,353 | +22% | $0 |
| D | 2025-09-04 | 2025-09-02 | ELV | Craig Ryan R | EVP, Chief HR Off | A - Grant | $0.00 | +3,690 | 3,690 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-02 | A | A | 970 | $0.00 | 5,353 | D | — | — | (F1) Represents restricted share units. Restrictions lapse as follows: 323 shares each on 9/2/2026 and 9/2/2027, and 324 shares on 9/2/2028. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2025-09-02 | A | A | 3,690 | $0.00 | 3,690 | D | $322.33 · — to 2035-09-02 | 3,690 Common Stock | (F2) The option represents a right to purchase a total of 3,690 shares, and is exercisable in three annual installments of 1,230 shares, beginning on 9/2/2026, which is the one-year anniversary of the option grant date. |